When AI Gives Off-Label Drug Advice: What Pharma Must Track Now
A patient asks ChatGPT whether their antidepressant can help with chronic pain. Another asks Gemini if a GLP-1 drug will […]
A patient asks ChatGPT whether their antidepressant can help with chronic pain. Another asks Gemini if a GLP-1 drug will […]
When a patient types “is Ozempic safe for someone with a history of pancreatitis?” into ChatGPT, they get an answer
Most pharmaceutical companies still don’t know what ChatGPT says about their drugs. They don’t know whether Perplexity recommends their biologic
A patient with rheumatoid arthritis does not always call her rheumatologist first anymore. She opens ChatGPT and asks whether switching
Artificial intelligence is beginning to change not only how patients search for information about medicines, but also how journalists research
A patient asks ChatGPT if it is safe to skip a dose of a heart medication because they feel dizzy.
There are two kinds of medication questions: the ones you ask when you’re starting, and the ones you ask when
There are two kinds of dosing confusion: the kind that comes from misunderstanding a label, and the kind that comes
In March 2023, the FDA updated the prescribing information for Dupixent (dupilumab) to include new warnings around eosinophilic conditions. Physicians
A physician in Cincinnati asks ChatGPT whether semaglutide reduces cardiovascular events in patients without diabetes. The AI answers confidently, citing
Every day, millions of patients type questions about their prescriptions into ChatGPT, Perplexity, Gemini, and Claude. They ask whether Ozempic
Ask ChatGPT whether Ozempic is safe for patients with a history of pancreatitis. Then ask Gemini. Then ask Perplexity. You
Sign in or create a free account to read this DrugChatter article